Herpes simplex virus vectors for gene therapy

Biogenic Amines

Volumn 14, Issue 5, 1998, Pages 477-497

  Latchman, D S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Gene therapy; Herpes simplex virus; Neurological disease; Virus vectors

Indexed keywords

PLASMID VECTOR; VIRUS DNA;

DNA REPLICATION ORIGIN; EXPRESSION VECTOR; GENE EXPRESSION; GENE INSERTION; GENE TARGETING; GENE THERAPY; HELPER VIRUS; HERPES SIMPLEX VIRUS; NEUROPATHY; NONHUMAN; REVIEW; VIRUS INFECTION; VIRUS LATENCY; VIRUS RECOMBINANT; VIRUS REPLICATION;

DNA VIRUSES; HERPES; SIMPLEXVIRUS;

EID: 0031698545     PISSN: 01688561     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Aigner, L., Arber, S., Kapfhammer, J.P., Laux, T., Schneider, G., Botteri, F., Brenner, H-R. and Caroni, P. (1995). Over expression of the neural growth associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell, 83: 269-278.
2. Amin, V., Cumming, D.V.E. and Latchman, D.S. (1996). Over-expression of heat shock protein 70 protects neuronal cells against both thermal and ischaemic stress but with different efficiencies. Neurosci. Lett., 206: 45-48.
3. Backlund, E-O., Grandberg, P-O., Hamberger, B., Knutsson, E., Martensson, A., Sedirall, G., Seigar, A. and Olson, L. (1985). Transplantation of adrenal medulla tissue to striatum in Parkinsonism. J. Neurosurgery, 62: 169-173.
4. Bloom, D.C., Maidment, N.tT, Tan, A., Dissette, V.B., Feldman, L.T. and Stevens, J.G. (1995). Long term expression of a reporter gene from latent herpes simplex virus in the rat hippocampus. Mol. Brain Res., 31: 48-60.
5. Chiocca, A.E., Choi, B.B., Cai, W., DeLuca, N., Schaffer, P.A., DiFiglia, M., Breakefield, X.O. and Martuzaj, R.L. (1990). Transfer and expression of the lac Z gene in rat brain neurons by herpes simplex virus mutants. New Biol., 266: 739-746.
6. Coffin, R.S., Howard, M.K., Cumming, D.V.E., Dollery, C.M., McEwan, J., Yellon, D.M., Marber, M.S., Maclean, A.R., Brown, S.M. and Latchman, D.S. (1996a). Gene delivery to cardiac cells in vitro and in vivo using herpes simplex virus vectors. Gene Ther., 3: 560-566.
7. Coffin, R.S. and Latchman, D.S. (1996a). Herpes Simplex Virus based vectors. In: Genetic manipulation of the nervous system, D.S. Latchman (Ed.), Academic Press.
8. Coffin, R.S., Maclean, A.R., Latchman, D.S. and Brown, S.M. (1996b) Gene delivery to the central and peripheral nervous systems of mice using HSV1 ICP34-5 deletion mutant vectors. Gene Ther., 3: 886-891.
9. Coffin, R.S., Thomas, S.K., Thomas, N.S.B., Lilley, C.E., Pizzey, A.R., Griffiths, C.H., Gibb, B.J., Wagstaff, M.J.D., Inges, S.J., Binks, M.H., Chain, B.M., Thrasher, A.J., Rutault, K. and Latchman, D.S. (1998). Pure populations of transduced primary human cells can be produced using GFP expressing herpes virus vectors and flow cytometry. Gene Ther. (in press).
10. Croen, K.D., Ostrove, J.M., Dragovic, L.J., Smialek, J.E. and Straus, S.E. (1987). Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene antisense transcript by in situ hybridization. New Eng. J. Med., 317: 1427-1432.
11. Dobson, A.T., Margolis, T.P., Gomes, W.A. and Feldman, L.T. (1995). In vivo deletion analysis of the herpes simplex virus type 1 latency associated transcript promoter. J. Virol., 69: 2264-2270.
12. Dobson, A.T., Margolis, T.P., Sedarati, F., Stevens, J.G. and Feldman, L.T. (1990). A latent nonpathogenic HSV-1 derived vector stably expresses β-galactosidase in mouse neurons. Neuron, 5: 353-360.
13. During, M.J., Naegele, J.R., O'Malley, K.L. and Geller, A.I. (1994). Long-term behavioural recovery in parkinsonian rats by an HSV vector expressing tyrosine hydoxylase. Science, 266:1399-1403.
14. Fedderoff, H.J., Geschwind, M.D., Geller, A.I. and Kessler, J.A. (1992). Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglion. Proc.Natl.Acad.Sci. USA, 89:1636-1640.
15. Fink, D.J., DeLuca, N.A., Goins, W.F. and Glorioso, J.C. (1996). Gene transfer to neurons using herpes simplex virus-based vectors. Annu. rev. Neurosci., 19: 265-287.
16. Fink, D.J., Sternberg, L.R., Weber, P.C., Mata, M., Goins, W.F. and Glorioso, J.C. (1992). In vivo expression of β-galactosidase in hippocampal neurons by HSV-mediated gene transfer. Hum. Gene Ther., 3: 11-19.
17. Geller, A.I. and Breakefield, X.O. (1990). A defective HSV-1 vector expresses E. coll β-galactosidase in cultured CNS neurons. Proc.Natl.Acad.Sci. USA, 87: 1149-1153.
18. Geschwind, M.D., Hartnick, C.J., Liu, W., Amat, J., Van de Water, T.R. and Federoff, H.J. (1996). Defective HSV-1 vector expressing BDNF in auditory ganglia elicits neurite outgrowth: Model for treatment of neuron loss following cochlear degeneration. Hum. Gene Ther., 7: 173-182.
19. Goins, W.F., Stenberg, L.R., Croen, K.D., Krause, P.R., Hendricks, R.L. Fink, D.J., Straus, S.E., Levine, M. and Gloriso, J.C. (1994). A novel latency-associated promoter is continued within the herpes simplex virus type 1 UL flanking repeats. J. Virol., 68: 2239-2252.
20. Haase, G., Kennel, P., Pettmann, B., Vigne, E., Akli, A., Revah, F., Schmalbruch, H. and Kahn, A. (1997). Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nature Med., 3, 429-436.
21. Ho, D.Y. and Mocarski, E.S. (1988). B-galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus infected mouse. Virology, 167: 279-283.
22. Ho, D.Y. and Mocarski, E.S. (1989). Herpes Simplex virus latent RNA (Lat) is not required for latent infection in the mouse. Proc. Natl. Acad. Sci. USA, 86: 7596-7600.
23. Huard, J. and Glorioso, J.C. (1995). Herpes simplex virus type 1 vector mediated gene transfer to muscle. Gene Ther., 2: 385-392.
24. Kaplitt, M.G., Pfaus, J.G. , Kleopoulous, S.P., Hanlon, B.A., Rabkin, S.D. and Pfaff, D.W. (1991). Expression of a functional foreign gene in adult mammalaian brain following in vivo transfer via a herpes simplex virus type 1 defective viral vector. Mol. Cell. Neurosci., 2: 320-330.
25. Kennedy, G.E. (1997). Potential use of herpes simplex virus (HSV) vectors for gene therapy of neurological disorders. Brain, 120: 1245-1259.
26. Kwong, A.D. and Frenkel, N. (1985). The herpes simplex virus amplicon IV. Efficient expression of a chimeric chicken ovalbumin gene amplified within defective virus genomes. Virology, 142: 421-425.
27. Latchman, D.S. (1990). Molecular biology of herpes simplex virus latency. Int. J. Exp. pathol., 71: 133-141.
28. Latchman, D.S. (1994). Herpes Simplex virus vectors for gene therapy. Mol. Biotechnol., 2: 179-195.
29. Lawrence, M.S., Ho, D.Y., Sun, G.H., Steinberg, G.K. and Sapolsky, R.M. (1996). Over expression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J. Neuroscience, 16: 486-496.
30. Lawrence, M., McLaughlin, J., Sun, G., Ho, D., McIntosh, L., Kunis, D., Sapolsky, R. and Steinberg, G. (1997). Herpes simplex viral vectors expressing Bcl-2 are neuro-protective when delivered after a stroke. J. Cereb. Blood Flow Metab., 17: 740-744.
31. Leib, D.A. and Olivo, P.D. (1993). Gene delivery to Neurons: is herpes simplex virus the right tool for the job? BioEssays, 15: 547-554.
32. Lokensgard, J.R., Bloom, D.C., Dobson, A.T. and Feldman, L.T. (1994). Long term promoter activity during herpes simplex virus latency. J.Virol., 68: 7148-7158.
33. Lu, B., Gupta, S. and Federoff, H. (1995). Ex vivo hepatic gene transfer in mouse using a defective herpes simplex virus-1 vector. Hepatology, 21: 752-759.
34. Maclean, A.R., Fareed, M.U., Robertson, L., Harland, J. and Brown, S.M. (1991). Herpes Simplex Virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence related sequences in Glasgow strain 17+ between immediate-early gene 1 and the 'a' sequence. J. Gen. Virol., 72: 631-639.
35. Margolis, T.P., Bloom, D.C., Dobson, A.T., Feldman, L.T. and Stevens, J.G. (1993). Decreased reporter gene expression during latent infection with HSV LAT promoter constructs. Virology, 197: 585-592.
36. Margolis, T.P., Sederati, F., Dobson, A.T., Feldman, L.T. and Stevens, J.G. (1992). Pathways of viral gene expression during acute neuronal infection with HSV-1. Virology, 189: 150-160.
37. Miller, A.G., Adam, M.A. and Miller, A.D. (1990). Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol., 10: 4239-4242.
38. Opacka-Juffry, J., Ashworth, S., Hume, S., Martin, D., Brooks, D. and Blunt, S. (1995). rhGDNF protects nigrostriatal DA neurons against the neurotoxin 6-OHDA: an in vivo study using microdialysis and positron emission tomography. Neuro. Report, 7: 348-352.
39. Palella, T.D., Silverman, L.J., Schroll, C.T., Homa, F.L., Levine, M. and Kelley, W.N. (1988). Herpes simplex virus mediated human hypoxanthine-guanine phosphoribosyl transferase gene transfer into neuronal cells. Mol. Cell. Biol., 8: 457-460.
40. Roizman, B. and Sears, A.E. (1987). An inquiry into the mechanisms of herpes simplex virus latency. Ann. Rev. Microbiol., 41: 543-571.
41. Sacks, W.R., Greene, C.C., Aschmann, D.P. and Schaffer, P.A. (1985). Herpes simplex virus type 1 ICP27 is an essential regulatory protein. J. Virol., 55: 796-805.
42. Spaete, R.R. and Frenkel, N. (1982). The herpes simplex virus amplicon: a new eukaryotic defective virus cloning amplifying vector. Cell, 30: 295-304.
43. Stevens, J.G., Wagner, E.K., Devi-Rao, G.B., Cook, M.L. and Feldman, L.T. (1987). RNA complementary to a herpes virus alpha gene mRNA is prominent in latently infected neurons. Science, 235: 1056-1059.
44. Tsuda, M. and Imaokea, T. (1996). Direct Injection of Plasmid DNA into the Brain. In: Genetic Manipulation of the Nervous System, D.S. Latchman (Ed.), Academic Press, London, pp. 235-248.
45. Wang, Q., Guo, J. and Jia, W. (1997). Intracerebral recombinant HSV-1 vector does not reactivate latent HSV-1. Gene Ther., 4: 1300-1304, 1997.
46. Wyatt, S., Mailhos, C. and Latchman, D.S. (1996). Trigeminal ganglion neurons are protected by the heat shock proteins hsp70 and hsp90 from thermal stress but not from programmed cell death following NGF withdrawal. Brain Res., 39: 52-56.